Episode 42: Breaking Barriers in Genomics Accessibility with Hannah Dose episode artwork

EPISODE · Jan 22, 2025 · 58 MIN

Episode 42: Breaking Barriers in Genomics Accessibility with Hannah Dose

from The DNA of Things with Dr. Jeremy Koenig · host Dr. Jeremy Koenig

In this episode, we dive deep into the remarkable journey of Hannah Dose, the Co-Founder and CEO of AU Genomics, a trailblazer in genomics innovation. From pioneering CRISPR research in plant sciences to transforming human health and accessibility in genomics, Hannah's story is one of resilience and groundbreaking achievements. She shares her insights on bridging gaps in health and science, her company’s journey to winning the XPRIZE for rapid COVID testing, and how AU Genomics is making genomic tools more accessible. Tune in to explore how innovation, passion, and a commitment to equity are reshaping the future of genomics. Episode Highlights:Innovative Genomics Solutions: Hannah Dose shares how AU Genomics is tackling high-stakes challenges with bespoke next-generation sequencing solutions, making advanced genomic tools accessible to more people.CRISPR Breakthroughs: Hannah's early work in plant sciences using CRISPR technology laid the foundation for her pivot to human health and genomics accessibility.XPRIZE Victory: AU Genomics’ rapid, cost-effective COVID-19 saliva test not only won the prestigious XPRIZE but also highlighted the team's dedication to equitable healthcare solutions.Addressing Global Health Gaps: Hannah emphasizes the critical need to overcome logistical, financial, and regulatory barriers that hinder equitable access to genomics research and healthcare across borders.Empowering Underserved Communities: AU Genomics actively supports marginalized researchers and communities by enabling access to innovative tools and methods previously out of reach.AI in Genomics: The integration of AI and advanced computational tools is revolutionizing data analysis, lowering costs, and driving innovation in the genomics space.Collaboration and Mentorship: Hannah underscores the importance of building a network of experts to complement your skills and push the boundaries of innovation.The Future of Genomics: AU Genomics aims to foster creative, inclusive, and collaborative environments where bold ideas can be tested, transforming the genomics landscape for the better.https://www.augenomics.com/ LINKS:https://www.drjeremykoenig.com/https://www.instagram.com/drjeremykoenig/https://www.youtube.com/@drjeremykoenigHere's the link for this week's episode: https://drjeremykoenig.substack.com/.

Episode metadata supplied by the publisher feed · Published Jan 22, 2025

Embed this episode

In this episode, we dive deep into the remarkable journey of Hannah Dose, the Co-Founder and CEO of AU Genomics, a trailblazer in genomics innovation. From pioneering CRISPR research in plant sciences to transforming human health and accessibility in genomics, Hannah's story is one of resilience and groundbreaking achievements. She shares her insights on bridging gaps in health and science, her company’s journey to winning the XPRIZE for rapid COVID testing, and how AU Genomics is making geno...

Distinct summary based on available episode metadata or transcript content.

NOW PLAYING

Episode 42: Breaking Barriers in Genomics Accessibility with Hannah Dose

0:00 58:58

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of The DNA of Things with Dr. Jeremy Koenig?

This episode is 58 minutes long.

When was this The DNA of Things with Dr. Jeremy Koenig episode published?

This episode was published on January 22, 2025.

Can I download this The DNA of Things with Dr. Jeremy Koenig episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!